Last reviewed · How we verify
Trinity Evolution
At a glance
| Generic name | Trinity Evolution |
|---|---|
| Also known as | Allograft, Mesenchymal Stem Cells |
| Sponsor | Orthofix Inc. |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion
- Trinity Evolution in Posterior or Transforaminal Lumbar Interbody Fusion (PLIF/TLIF)
- Trinity Evolution in Anterior Cervical Disectomy and Fusion (ACDF)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Trinity Evolution CI brief — competitive landscape report
- Trinity Evolution updates RSS · CI watch RSS
- Orthofix Inc. portfolio CI